Early diagnosis of Alzheimer's disease: Is MCI too late?

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

The field of aging and dementia research is advancing rapidly toward the stage of earlier identification of clinical symptoms. Ultimately, clinicians would like to be able to identify individuals who are asymptomatic but at risk for developing dementia. In the interim, the construct of mild cognitive impairment (MCI) has come to represent an intermediate clinical state between the cognitive changes of aging and the very earliest features of Alzheimer's disease. A great deal of research has been generated in the past several years on MCI, and epidemiologic studies are characterizing its frequency in the general population. There are predictors of a more rapid progression from MCI to Alzheimer's disease, and these studies are suggesting techniques for altering future clinical trials. The neuropathology of MCI is intermediate between the neuropathologic changes of aging and fully developed Alzheimer's disease. The breadth of research in MCI is expanding and will be reviewed.

Original languageEnglish (US)
Pages (from-to)324-330
Number of pages7
JournalCurrent Alzheimer Research
Volume6
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Early Diagnosis
Alzheimer Disease
Dementia
Research
Epidemiologic Studies
Cognitive Dysfunction
Clinical Trials
Population

Keywords

  • Aging
  • Alzheimer's disease
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Early diagnosis of Alzheimer's disease : Is MCI too late? / Petersen, Ronald Carl.

In: Current Alzheimer Research, Vol. 6, No. 4, 08.2009, p. 324-330.

Research output: Contribution to journalArticle

@article{6b0ca5e954a24e1ba391a73aba0832d0,
title = "Early diagnosis of Alzheimer's disease: Is MCI too late?",
abstract = "The field of aging and dementia research is advancing rapidly toward the stage of earlier identification of clinical symptoms. Ultimately, clinicians would like to be able to identify individuals who are asymptomatic but at risk for developing dementia. In the interim, the construct of mild cognitive impairment (MCI) has come to represent an intermediate clinical state between the cognitive changes of aging and the very earliest features of Alzheimer's disease. A great deal of research has been generated in the past several years on MCI, and epidemiologic studies are characterizing its frequency in the general population. There are predictors of a more rapid progression from MCI to Alzheimer's disease, and these studies are suggesting techniques for altering future clinical trials. The neuropathology of MCI is intermediate between the neuropathologic changes of aging and fully developed Alzheimer's disease. The breadth of research in MCI is expanding and will be reviewed.",
keywords = "Aging, Alzheimer's disease, Mild cognitive impairment",
author = "Petersen, {Ronald Carl}",
year = "2009",
month = "8",
doi = "10.2174/156720509788929237",
language = "English (US)",
volume = "6",
pages = "324--330",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Early diagnosis of Alzheimer's disease

T2 - Is MCI too late?

AU - Petersen, Ronald Carl

PY - 2009/8

Y1 - 2009/8

N2 - The field of aging and dementia research is advancing rapidly toward the stage of earlier identification of clinical symptoms. Ultimately, clinicians would like to be able to identify individuals who are asymptomatic but at risk for developing dementia. In the interim, the construct of mild cognitive impairment (MCI) has come to represent an intermediate clinical state between the cognitive changes of aging and the very earliest features of Alzheimer's disease. A great deal of research has been generated in the past several years on MCI, and epidemiologic studies are characterizing its frequency in the general population. There are predictors of a more rapid progression from MCI to Alzheimer's disease, and these studies are suggesting techniques for altering future clinical trials. The neuropathology of MCI is intermediate between the neuropathologic changes of aging and fully developed Alzheimer's disease. The breadth of research in MCI is expanding and will be reviewed.

AB - The field of aging and dementia research is advancing rapidly toward the stage of earlier identification of clinical symptoms. Ultimately, clinicians would like to be able to identify individuals who are asymptomatic but at risk for developing dementia. In the interim, the construct of mild cognitive impairment (MCI) has come to represent an intermediate clinical state between the cognitive changes of aging and the very earliest features of Alzheimer's disease. A great deal of research has been generated in the past several years on MCI, and epidemiologic studies are characterizing its frequency in the general population. There are predictors of a more rapid progression from MCI to Alzheimer's disease, and these studies are suggesting techniques for altering future clinical trials. The neuropathology of MCI is intermediate between the neuropathologic changes of aging and fully developed Alzheimer's disease. The breadth of research in MCI is expanding and will be reviewed.

KW - Aging

KW - Alzheimer's disease

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=69149095731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69149095731&partnerID=8YFLogxK

U2 - 10.2174/156720509788929237

DO - 10.2174/156720509788929237

M3 - Article

C2 - 19689230

AN - SCOPUS:69149095731

VL - 6

SP - 324

EP - 330

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 4

ER -